ALX ONCOLOGY HOLDINGS INC - 8-K Filing
ALX Oncology reports Q3 2026 net loss of $21.8 million and maintains cash runway through first half of 2028. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)
Tickers: $ALXO
Read the full article at SEC EDGAR
Part of the story Creative Media & Community Trust Reports Strong Q3 2026 Earnings and Debt Reduction (6 articles)